Status:
COMPLETED
Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Peptic Esophagitis
Peptic Ulcer
Eligibility:
All Genders
18+ years
Brief Summary
Fecal calprotectin is a very sensitive non-invasive inflammation marker in the detection of inflammatory bowel disease and, to a lesser degree, has also proven to be useful in adenomatous polyps, neop...
Eligibility Criteria
Inclusion
- All patients referred for upper gastrointestinal endoscopy for any reason
- Older than 18 years
Exclusion
- Patients who are not able to provide informed consent
- Patients who are not able to provide a stool sample
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
287 Patients enrolled
Trial Details
Trial ID
NCT00920400
Start Date
March 1 2008
End Date
December 1 2009
Last Update
January 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology & Hepatology
Basel, Basel-Stand, Switzerland, 4031